Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients. Turkey Cohort, Prospective, Observational, Comparative Study

NCT06223932 is registered in ClinicalTrials.gov with Serap Yavuz as lead sponsor.

NCT NCT06223932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06223932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients. Turkey Cohort, Prospective, Observational, Comparative Study
Lead sponsor
Serap Yavuz
Phase
Observational
Overall status
Unknown status
Start date
July 7, 2022
Completion date
February 29, 2024
Enrollment
2,600 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2 infection